MEDPLUS — MedPlus Health Services Balance Sheet
0.000.00%
- IN₹73.49bn
- IN₹81.59bn
- IN₹68.92bn
Annual balance sheet for MedPlus Health Services, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,576 | 2,875 | 1,650 | 4,399 | 5,925 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 439 | 195 | 282 | 270 | 625 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16,317 | 14,807 | 15,676 | 18,435 | 20,687 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,715 | 11,144 | 12,014 | 12,618 | 15,772 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 25,940 | 27,967 | 30,048 | 33,601 | 39,325 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,590 | 4,766 | 5,259 | 5,766 | 6,893 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11,763 | 13,055 | 14,269 | 16,195 | 19,572 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 14,178 | 14,912 | 15,779 | 17,406 | 19,754 |
| Total Liabilities & Shareholders' Equity | 25,940 | 27,967 | 30,048 | 33,601 | 39,325 |
| Total Common Shares Outstanding |